Trejon Brignac
Family · New Orleans, LANPI 1891285516
Payments from drug & device makers
Across 73 payments — averaging $29.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$640
- AbbVie$283
- Lilly USA, LLC$169
- Teva Pharmaceuticals USA, Inc.$151
- Alkermes, Inc.$127
- Collegium Pharmaceutical, Inc.$122
- plus $685 from 15 others
What the payments were for
- Food & beverage$2,177100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 9 | $640 |
| AbbVie | 11 | $283 |
| Lilly USA, LLC | 7 | $169 |
| Teva Pharmaceuticals USA, Inc. | 3 | $151 |
| Alkermes, Inc. | 3 | $127 |
| Collegium Pharmaceutical, Inc. | 1 | $122 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $98 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $83 |
| Bayer | 5 | $81 |
| Boehringer Ingelheim | 5 | $75 |
| E.r. Squibb & Sons, L.L.C. | 4 | $59 |
| Ardelyx, Inc. | 2 | $45 |
| Johnson & Johnson | 3 | $43 |
| Gilead | 2 | $40 |
| Ironwood Pharmaceuticals, Inc | 2 | $37 |
| Exact Sciences | 2 | $34 |
| Pfizer | 2 | $32 |
| Sanofi Pasteur Inc. | 1 | $18 |
| Novartis | 1 | $14 |
| Astellas Pharma US Inc | 1 | $13 |
| Lundbeck LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- REXULTI$247
- ABILIFY MAINTENA$247
- ABILIFY ASIMTUFII$247
- JORNAY PM$122
- VRAYLAR$117
- Austedo XR$114
How this compares
$2,177 in reported general payments places this provider in the 75th percentile of 3,610 family providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 12 | $15,475 |
| JanuviaSitagliptin Phosphate | 13 | $7,702 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 15 | $2,711 |
| Ultra-Fine Short Pen NeedlePen Needle, Diabetic | 17 | $1,026 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 29 | $690 |
| Atorvastatin Calcium | 102 | $586 |
| Amlodipine Besylate | 98 | $517 |
| Gabapentin | 35 | $480 |
| Diclofenac Sodium | 14 | $400 |
| Amitriptyline Hcl | 15 | $331 |
| Fluticasone Propionate | 17 | $286 |
| Metoprolol Succinate | 21 | $274 |
| Losartan Potassium | 53 | $269 |
| Ezetimibe | 28 | $268 |
| Quetiapine Fumarate | 30 | $245 |
Paid to pharmacies, not to this prescriber.
Other family in New Orleans
- Erin PierceNew Orleans$261K
- Tavell KindallNew Orleans$194K
- Robert ByramNew Orleans$49K
- Amy SchmittNew Orleans$48K
- Eric BabineauxNew Orleans$32K
- Cherie AlbroNew Orleans$29K
- Aimee ScroggsNew Orleans$20K
- Kelly BaquetNew Orleans$18K
- Lori LemoineNew Orleans$17K
- Jennifer GreenheckNew Orleans$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.